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Condensed Abstract 
 
Smoking increases STEMI risk. This study is the first to differentiate the risk between genders 
and age groups. STEMI rates per population group were created using retrospective admission 
and general population data over a 5 year period. Compared to their non-smoking counterparts, 
smoking females and a greater risk of STEMI risk than male smokers. This difference was 
present across all ages, but the difference was greatest in the 50 to 64 age range. Female 
smokers in the less than 50 age group had the greatest increased STEMI risk. This study 
quantifies smoking risk in an approachable format to encourage patients in smoking cessation. 
 
Abstract 
 
Background: Smoking is a well documented cause of STEMI. The differential effect between 
genders has yet to be quantified. 
Objectives: To differentiate the impact of smoking on increased risk of ST-segment elevation 
myocardial infarction (STEMI), between genders. 
Methods: A retrospective ecological cohort study. All patients at a UK tertiary cardiothoracic 
centre who presented between 2009 to 2014 with acute STEMI were combined with population 
data to generate incidence rates of STEMI. Age-standardised incidence rate ratios (IRR) using 
the Poisson distribution were calculated comparing STEMI rates between smokers and non-
smokers stratified by gender and three age groups (18-49, 50-64, >65 years). 
Results: 3,343 patients presented over 5,639,328 person-years. Peak STEMI rate for current 
smokers was in the 70-79 age range for females (235/100,000 pt/yrs) and 50-59 (425/100,000 
pt/yrs) in males. Smoking was associated with a significantly greater increase in STEMI rate 
for females than males (IRR 6.62, CI: 5.98 to 7.31 vs 4.40, CI: 4.15 to 4.67). The greatest 
increased risk was in females aged 18-49 (13.22, CI: 10.33 to 16.66 vs 8.60, CI: 7.70 to 9.59 
in males). The greatest risk difference was in the 50-64 year group with IRR of 9.66 (CI: 8.30 
to 11.18) in females and 4.47 (CI: 4.10 to 4.86) in males. 
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Conclusions: This study quantifies the differential impact of smoking between genders, with 
females having a significantly increased risk of STEMI than males. This information 
encourages continued efforts to prevent smoking uptake and promote cessation. 
 
Keywords: Gender, Smoking, Incidence, STEMI 
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List of abbreviations: 
 
CHD ± Coronary heart disease  
CI ± Confidence interval 
IHS ± Integrated Household Survey 
IRR ± Incidence rate ratio 
LAD ± Left anterior descending 
LMS ± Left main stem 
ONS ± Office for National Statistics 
PCI ± Percutaneous coronary intervention 
RCA ± Right coronary artery 
STEMI ± ST-segment elevation myocardial infarction 
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Introduction 
Cardiovascular disease remains the leading cause of mortality worldwide, with an increasing 
prevalence. In 2000, this mortality was recorded at 28%, whereas in 2015 this had increased to 
31%.(1,2) Heart disease also accounts for over one-quarter of all deaths in the USA.(3) Acute 
STEMI is amongst the most life-threatening manifestations of cardiovascular disease, affecting 
all age groups, resulting in death within 30 days in 5.7-11.0% of cases.(4-6)  
In 2015, it was estimated that there were 933.1 million smokers worldwide, with 82.3% of 
these being male.(7) ,QFRQWUDVWRI WKH8.¶VPLOOLRQVPRNHUVWKHUH LVDPXFKQDUURZHU
gender divide:(8) In 2016, 17.7% of the male population and 14.1% of the female population 
were smoking, the lowest recorded values since 2010.(8) The comparative similarity of 
smoking prevalence between genders in the UK makes the effects of smoking easier to 
compare. Studies assessing gender-differentiated risk of ischaemic heart disease attributable to 
smoking have yielded varying results. A Danish study found that smoking was a greater risk 
factor for all acute coronary syndromes in women, compared to men.(9) A study of a large 
Swedish registry has identified smoking as a more significant risk for STEMI for women than 
men, under the age of 65.(10) Older studies have either suggested an increased risk of 
myocardial infarction for women compared to men,(11,12) no difference in risk 
(Framingham),(13) or less risk than men.(14) 
Although the magnitude of risk of acute STEMI attributable to smoking has been studied (15), 
none have quantified and compared the incidence of STEMI associated with smoking between 
genders and within different age groups. This study aims to assess smoking as an independent 
risk factor for STEMI, and determine differences in risk between age and gender groups. 
 
Methods 
In this retrospective ecological cohort study, data were compiled for all patients presenting 
with acute STEMI managed by primary PCI, in the South Yorkshire region over a five year 
period, between 4th January 2009 and 31st July 2014. 
Employing a departmental database mandated by national audit processes, patients were 
identified and their individual patient case-notes examined. Data collected included patient age, 
gender, smoking status, other key cardiovascular risk factors, and cardio-protective drugs taken 
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prior to STEMI onset. Culprit artery of STEMI was also recorded. Ex-smokers were described 
as being abstinent for a minimum of 28 days prior to STEMI, although duration of smoking 
cessation was omitted from patient case notes in 38% of cases of ex-smoker. 
Statistical Methods 
Differences in the normally distributed continuous variables of ages within genders were 
compared using independent samples T tests. Differences between genders in categorical 
variables, other STEMI risk factors and pre-STEMI cardiac medications and the percentage of 
cases attributed to culprit arteries were compared using chi-squared tests. 
STEMI incidence rates by age and gender were calculated, stratified by smoking status. These 
were derived by comparing the raw STEMI numbers, to the entire population served by the 
South Yorkshire Cardiothoracic centre, with data obtained from the Integrated Household 
Survey (IHS), from the United Kingdom Office for National Statistics (ONS). 
7KHVHFRQGGDWDVHWZDVGHULYHGIURPUHVSRQVHVIURP6RXWK<RUNVKLUHUHVLGHQWVDJHG\HDUV
participating in the Office for National Statistics Integrated Household Survey (ONS-IHS) 
between April 2009 and March 2012. The ONS-IHS asks randomly sampled respondents a 
range of topics using telephone or face-to-face interviews and is the biggest pool of UK social 
data after the census. It does not contain medical diagnoses due to the self-reported nature of 
the questionnaire. Respondents were asked both if they had ever smoked and if they currently 
smoked. Regional and/or national estimates of population responses are generated using a 
multi-stage population weighting procedure which accounts for probability of selection and 
adjusts for non-response, and have reported similar estimates to other social surveys. The 
weighted responses from the local authorities served by the cardiac centre were used to estimate 
population age and smoking status strata. 
 ൌ   
95% confidence intervals were obtained from the Poisson distribution. 
Incidence rate ratios (IRR) and their confidence intervals, indirectly standardised to account 
for age differences between the genders were calculated, and directly compared to assess 
differences in the impact of smoking on STEMI risk, between genders. Incidence rate ratios 
were calculated by age group by the formula: 
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 ൌ ሺሻ െ ሺሻ 
Relative risk of smoking associated STEMI was then compared between the genders, across 
the age groups by dividing the IRRs through each other. 
Ethics 
Permission for this study was gained from the Sheffield Teaching Hospitals Research and 
Development Department, using previously collected data from hospital records, extracted and 
anonymised to preserve patient confidentiality and abide with the Data Protection Act. At the 
VWXG\¶VFRQFHSWLRQDSSURYDOZDVQRWUHTXLUHGIURPWKH1+65HVHDUFK(WKLFV&RPPLWWHHIRU
retrospective studies of this sort. 
 
Results 
3,343 STEMIs were recorded within our five-year study period. Of these, 27.3% occurred in 
females whose mean presentation of age was 5.8 years older than males (66.6 vs 60.8, 
p=0.011). The prevalence of most risk factors and all pre-STEMI cardiac medications were 
similar (Table 1). However, hypertension, diabetes and history of cerebrovascular accident 
were significantly more common in females, whereas a previous history of myocardial 
infarction was more prevalent in males (Table 1). The proportion of STEMI patients who were 
current smokers were similar between genders (46.8% of female patients vs 47.6% of male 
patients). 
The distribution of culprit artery for STEMI was impacted by gender, age group and smoking 
status (Table 2). STEMI in females were more likely to involve the RCA (right coronary 
artery), and less likely to involve the circumflex. The RCA was involved less in the cases of 
the 18-49 year old age group. Current smokers were more likely to have the RCA as their 
culprit lesion, and less likely to involve the LAD (left anterior descending) artery. 
In smokers, the highest rate of STEMI was in the 50-59 year age group, at 286.3 (262.1 - 312.2) 
per 100,000, whereas in non-smokers, the highest rate was in the 70-79 year old group, at 95.1 
(82.7 - 108.9) per 100,000. An incidence rate graph displaying the raw STEMI figures versus 
the general population demonstrated a similar risk between ex- and never-smokers for STEMI 
incidence, with confidence intervals overlapping between the groups at every 10 year age group 
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(Figure 1). Figures 2 and 3 demonstrate the incidence rates of acute STEMI for different 
smoking groups at each 10 year age group, differentiated for gender (female and male, 
respectively), with similarity between non-smoking groups confirmed. These figures justified 
the combination of the ex-smoker and never-smoker groups for further comparison of the effect 
of smoking vs not smoking, by looking at age-standardised IRRs (Figure 4). 
Compared to their non-smoking counterparts, the STEMI risk was 6.62 times higher (CI: 5.98-
7.31) in female and 4.40 (CI: 4.15-4.67) in male smokers. Female smokers under 50 years ran 
the highest relative risk of acute STEMI, 13.22 (CI: 10.35-16.66) times greater than their non-
smoking counterparts. This was significantly higher than males of the same age group, with a 
smoking associated risk of 8.60 (7.70-9.59). 
The largest relative risk difference in smoking-associated STEMI was found in the middle-
aged (50-64), with female smokers being 9.66 (CI: 8.30-11.18) times increased risk of STEMI 
vs 4.47 (CI: 4.10-4.86) for males, indicating smoking is a more severe risk factor for women 
of this age group compared to men, by a factor of 2.16. Figure 5 demonstrates the relative risk 
of smoking associated STEMI for female smokers, compared to male smokers. 
 
Discussion 
Smoking is an established reversible risk factor for CHD. Our group has previously identified 
smoking as the causative agent for STEMI in nearly 50% of all cases,(16) and have highlighted 
that smoking poses the greatest risk in the young (under 50 years).(15) Despite this, there is no 
significantly increased mortality risk post STEMI according to smoking status.(17) Expanding 
from these previous studies, the established prevalence of risk factors at baseline have remained 
very similar.  
We have found that smoking increases STEMI risk in all patients, regardless of age or gender. 
However, this is the first study to quantify this risk and its differential effect according to 
gender, and its variation within age groups. Smoking increases STEMI risk in females more 
than males by a significant degree at all ages, with the largest risk difference present in the 
middle aged (50-64 years) group. However, the highest risk increase for both genders was in 
the youngest patients (18-49 years). This study emphasises the differential effect of smoking 
on STEMI risk between younger and older smokers. This is most striking in young females, in 
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whom smoking increases STEMI risk by over 13 times, with young male smokers at 8.6 times 
increased risk.  
The protective effects of endogenous oestrogens have long been known, due to their effects on 
serum lipid concentrations, and their effects on vessel walls, notably vasodilation and inhibiting 
response to injury, thus preventing the development of atherosclerosis.(18) It has been 
observed that oestrogen activity or production is inhibited by cigarette smoke.(19) This has 
been supported by studies finding statistically lower levels of serum oestrogen and increased 
failure rates of in-vitro fertilisation in smoking females compared to their age-matched 
counterparts.(19,20) Therefore, smoking poses a double risk to pre-menopausal women, with 
its causality to atherosclerosis as well as its disturbance on oestrogen levels.  
Men have also been found to have larger calibre coronary arteries than women in a large study, 
regardless of body habitus or left ventricular mass.(21) The pathological effect of smoking on 
STEMI is multifactorial and is attributable to thrombosis, endothelial dysfunction and 
inflammation. Whereas artherogenic change and a hypercoagulable state will have similar 
effects regardless of arterial lumen diameter, chronic inflammation may lead to a greater degree 
of arterial narrowing in women than men, due to the already reduced calibre vessel.(22-24) 
This could result in female smokers having further reduced coronary artery diameter than men, 
compared to non-smokers. Furthermore, it has been suggested that the aetiology of female 
STEMI may differ from males. Whilst atherosclerotic change is the main culprit for both 
genders, other mechanisms have been recognised as more prevalent in female STEMI patients: 
vasospasm, vasculitis, fibromuscular dysplasia, spontaneous coronary artery dissection and 
plaque erosion (as opposed to plaque rupture).(25) It is highly likely that cigarette smoking 
perpetuates some of these extra-atherosclerotic events, thus imposing a greater increase in 
STEMI risk for women. For example nicotine, a key component of cigarette smoke induces 
vasospasm, a mechanism of STEMI known to be more common in females.(22,25) 
STEMI patients present later and receive less standardised treatment if they are female, 
resulting in greater mortality.(25) This discrepancy in outcomes is mirrored at all stages of risk 
prevention for CHD. In a study of 172 physicianVWKH³DWWLWXGHVWXG\´found that physicians 
perceived coronary artery disease in males as being more important than in females. Despite 
identical demographics, laboratory results and degree of atherosclerotic disease, preventative 
therapy was prescribed significantly more often in male than female patients.(26) Whilst this 
study did not evaluate differences in smoking cessation advice between genders, others have, 
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and we may speculate that smoking is considered less of a cardiac risk for females than for 
males, and therefore advice may differ between genders.(27,28) 
The similarity in STEMI risk for ex- and never-smokers has been identified in this study. This 
suggests marked reversibility in STEMI risk by cessation, possibly in as little as a few weeks 
or months. Whilst chronic atherosclerotic change is unlikely to be affected, it is plausible that 
risk of acute events, including thrombosis and vasospasm quickly regress with 
cessation.(29,30) This interesting observation carries a strong public health message to 
encourage smoking abstinence. Exploring the reversibility of harm from smoking for 
cardiovascular risk is a potential avenue for future research.  
As a cohort study, this ensured all patient groups were equally and fully represented from the 
South Yorkshire region, with a reduction in the risk of group under-representation. The 
population data gained from the ONS provided accurate denominators to create genuine 
STEMI rates, that could be applied both to the statistics of the study, as well as to clinical 
advice, within the study region. 
Study Limitations 
This study categorised people as current, ex-, or never-smokers. However this study did not 
provide information about volume of smoking or length of smoking cessation in ex-smokers. 
The retrospective nature of data collection may have resulted in variable accuracy of detail 
ZLWKLQVRPHSDWLHQWV¶SDVWPHGLFDOKLVWRU\IURPWKHFDVHQRWHV+RZHYHUDWWHPSWVZHUHDOVR
made to complete missing data from other database sources. This has potential to create error 
if a certain patient group was more at risk of not having paper records still on file, but was an 
unfortunate necessity of the study.  
This study includes only those presenting with STEMI as a candidate for PCI. It does not 
include those that died in the community prior to admission. Smoking may contribute to death 
before hospital admission, and this is therefore a potential source of bias. This study does not 
include other subtypes of acute coronary syndrome.  
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Conclusion 
This study is the first to quantify the differential effect of cigarette smoking between genders 
on STEMI risk. It has provided strong evidence that smoking incurs a greater STEMI risk to 
all female patients, compared to male. The differential effect of smoking was most significant 
in the middle-aged, by two-fold. However, the highest increased STEMI risk attributable to 
smoking was in young females (18-49), at over 13 times greater than non-smokers. 
This study also demonstrates that smoking cessation, regardless of age or gender, reduces 
STEMI risk to that of a never smoker, possibly within a month. Patients who smoke merit 
encouragement to give up their habit, and this study adds quantitative evidence to the benefits 
of doing so. The results shown here may also be used to demonstrate the negative effects of 
smoking to those who may otherwise seek to start, in particular young, otherwise healthy 
adults. 
  
12 
 
Clinical Perspectives 
Competency in Patient Safety: Cigarette smoking increases the risk of acute myocardial 
infarction in all, but to a greater degree in young women. This information encourages 
continued efforts to prevent smoking uptake and promote cessation. 
Translational outlook: Incidence rates demonstrate that ex-smokers have similar risk of 
STEMI as never-smokers. Further investigation into the reversibility of risk is warranted, and 
could lead to more compelling smoking cessation strategies. 
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Legend 
Figure 1. Incidence rate of STEMI in South Yorkshire (male and female), per 100,000 
years of patient risk by smoking status. 
The incidence rate of STEMI across the total population of South Yorkshire during the study 
period, with 95% CI, within 10-year age groups and by smoking status. Presenting cases were 
compared to population data regarding age, smoking status and gender to provide STEMI rates 
per 10-year age group. Current smokers had an incidence rate of STEMI great than ex or never 
smokers in all age groups, peaking at 50-59 years old. Ex and never smokers had similar 
incidence rates across all ages, with incidence peaking later in life than current smokers, at 70-
79 years old. 
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Figure 2. Incidence rate of STEMI in South Yorkshire (female), per 100,000 years of 
patient risk by smoking status  
The incidence rate of STEMI across the female population of South Yorkshire during the study 
period, with 95% CI, within 10-year age groups and by smoking status. Presenting cases were 
compared to population data regarding age, smoking status and gender to provide STEMI rates 
per 10-year age group. Female current smokers had a higher incidence rate of STEMI than ex 
or non-smoking females in all ages, with the peak incidence rate in the 70-79 years old group. 
The rates of STEMI for ex and never smokers were similar throughout, and noticeably smaller 
than the rates for male ex and never smokers shown in Figure 3. 
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Figure 3. Incidence rate of STEMI in South Yorkshire (male), per 100,000 years of patient 
risk by smoking status  
The incidence rate of STEMI across the male population of South Yorkshire during the study 
period, with 95% CI, within 10-year age groups and by smoking status. Presenting cases were 
compared to population data regarding age, smoking status and gender to provide STEMI rates 
per 10-year age group. Male current smokers had a greater incidence rate of STEMI than ex or 
never smokers across all ages, peaking in the 50-59 years old group. The rates of STEMI for 
ex and never smokers were similar throughout, and noticeably greater than the rates for female 
ex and never smokers shown in Figure 2. 
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Figure 4. Age standardised incidence rate ratios and 95% confidence intervals in current 
smokers 
The incidence rate ratios and 95% CI comparing the rate of STEMI between current and non-
smokers, which have been indirectly standardised to account for age differences between the 
genders. As demonstrated in Figures 1-3, incidence rates for STEMI in ex and never smokers 
were similar, and so were combined to compare current and non-smokers in Figure 4. 
Compared side by side, the incidence rate ratio is significantly greater for females than it is for 
males at all ages. This difference is most marked in the 50-64 years old age group. The greatest 
incidence rate ratio is found with female smokers in the 18-49 year old age group. At all ages, 
smoking increases the incidence rate of STEMI in females at a greater magnitude than it does 
in males. 
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Figure 5. Relative risk of acute STEMI in female smokers compared with male smokers 
The increased relative risk of STEMI that smoking incurred to female patients compared to 
males. By dividing female incidence rate ratios by male incidence rate ratios, the relative risk 
of female smokers suffering a STEMI is greater than 1.0 and therefore significant compared to 
male smokers.  
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Table 1. Comparison of cardiovascular risk factors and pre-STEMI drugs between 
genders 
The prevalence of cardiovascular risk factors and cardiac medications being taken by the 
presenting cases prior to STEMI, compared by gender. P-values are calculated with Chi-
squared tests. Female patients were more likely to have hypertension, diabetes and 
cerebrovascular disease. Male patients were more likely to have suffered a previous MI. Other 
risk factors and use of all cardiac medications were similar between the genders. 
Table 2. Comparison of the culprit artery for STEMI cases by gender, age and smoking 
status 
The culprit artery of all STEMI cases in the study. These are separated by gender, age group 
and smoking status respectively, and are displayed by value and percentage of cases. P-values 
were calculated using Chi-squared tests. Female patients were significantly more likely to have 
a lesion affecting the RCA and male patients had greater chance of affecting the circumflex 
artery. Patients in the 18-49 year were significantly less likely to have a lesion of the RCA. 
Current smokers were significantly more likely to have a lesion affecting the RCA. Never 
smokers were significantly less likely to have the circumflex as their culprit artery, but were 
much more likely to have a lesion of the LAD artery. Very few cases were attributed to the 
LMS. 
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Table 1: Comparison of cardiovascular risk factors and pre-STEMI drugs between genders  
Risk factor All Patients 
(%) 
Male patients 
(%) 
Female 
patients (%) 
P-value 
Hypertension 38.9 36.3 45.6 <0.001 
Family history 
of IHD 
39.4 39.9 38.0 0.321 
Diabetes 14.5 13.7 16.6 0.041 
Dyslipidaemia 34.9 35.4 33.6 0.349 
South Asian 
origin 
2.5 2.7 1.8 0.131 
Previous MI 19.5 20.5 17.0 0.024 
Chronic kidney 
disease 
1.2 1.1 1.5 0.377 
Congestive 
heart failure 
0.2 0.3 0.1 0.691 
Cerebrovascular 
disease 
5.4 4.8 6.8 0.025 
Peripheral 
vascular disease 
4.2 4.1 4.5 0.562 
Aspirin 15.7 16.1 15.0 0.446 
P2Y12 inhibitor 3.6 3.8 2.9 0.178 
Statin 21.4 22.5 19.3 0.050 
ACEi / ARB 16.6 16.4 17.6 0.425 
Beta blocker 11.8 11.9 11.9 0.956 
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Footnote:  
p-values are derived from chi-squared tests. 
MI = Myocardial infarction  
IHD = Ischaemic heart disease 
ACEi = Angiotensin converting enzyme inhibitor 
ARB = Angiotensin receptor blocker 
 
The prevalence of cardiovascular risk factors and cardiac medications being taken by the 
presenting cases prior to STEMI, compared by gender. P-values are calculated with Chi-
squared tests. Female patients were more likely to have hypertension, diabetes and 
cerebrovascular disease. Male patients were more likely to have suffered a previous MI. Other 
risk factors and use of all cardiac medications were similar between the genders. 
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Table 2: Comparison of the culprit artery for STEMI cases by gender, age and smoking status 
Variables Culprit Artery 
Left Main 
Stem (%) 
Left Anterior 
Descending 
(%) 
Circumflex (%) Right Coronary 
(%) 
 
Gender 
Female 1.3 39.9 10.6 50.5 
Male 1.8 42.3 14.4 45.1 
P-value 0.377 0.238 0.005 0.007 
 
Age 
group 
18-49 0.9 45.5 12.0 41.4 
50-64 1.7 40.9 14.7 47.2 
Over 64 1.9 40.8 12.7 47.9 
P-value 0.318 0.144 0.187 0.031 
 
 
Smoking 
Status 
Current 
smoker 
1.5 37.4 14.1 49.7 
Ex 
smoker 
2.2 41.3 15.1 44.8 
Never 
smoker 
1.4 50.7 9.8 42.1 
P-value 0.329 0.000 0.004 0.002 
 
The culprit artery of all STEMI cases in the study. These are separated by gender, age group 
and smoking status respectively, and are displayed by value and percentage of cases. P-values 
were calculated using chi-squared tests. Female patients were significantly more likely to have 
a lesion affecting the right coronary artery and male patients had greater chance of affecting 
the circumflex artery. Patients in the 18-49 year were significantly less likely to have a lesion 
of the right coronary artery. Current smokers were significantly more likely to have a lesion 
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affecting the right coronary artery. Never smokers were significantly less likely to have the 
circumflex as their culprit artery, but were much more likely to have a lesion of the left anterior 
descending artery. Very few cases were attributed to the left main stem. 
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Central Illustration 
 
The objective of this study was to determine differences in the risk of STEMI that smoking 
confers on men and women. A comparison of smokers with non-smokers by gender using age-
standardised incidence rate ratios (IRR) and their confidence intervals, showed that. smoking 
increased the risk of STEMI by a greater degree in females than in males, across all ages. 
Moreover, the greatest incidence rate ratio was in female smokers under 50 years of age, with 
a relative risk of STEMI 13.22 (CI: 10.35-16.66) times greater than that of their non-smoking 
female counterparts. The largest gender difference was in the 50-64 year old age group. This 
provides strong evidence to help encourage cessation in young smokers, particularly females. 
 
 
Age standardised incidence rate ratios and 95% confidence intervals in current smokers. 
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Box presentation 
x Smoking increases risk of STEMI in females more than it does in 
males. 
x The greatest increased risk of STEMI is in the female smokers under 
the age of 50. 
x Rates of STEMI in ex-smokers are similar to those of never smokers. 
x Smoking cessation must be encouraged in all, but particularly in the 
young and in women. Although their cardiovascular event risk is often 
perceived as low, these groups have the highest increased STEMI risk. 
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